- Facility License Renewal Reminder
- Additional Drug Rate Updates, CR 106867
- Linked files
- End of the 2022-2023 Seasonal Coverage for Use of Palivizumab Prophylaxis to Prevent Hospitalization from Severe Respiratory Syncytial Virus (RSV) Infection
- End of the 2022-2023 Seasonal Coverage for Use of Palivizumab Prophylaxis to Prevent Hospitalization from Severe Respiratory Syncytial Virus (RSV) Infection
- End of the 2022-2023 Seasonal Coverage for Use of Palivizumab Prophylaxis to Prevent Hospitalization from Severe Respiratory Syncytial Virus (RSV) Infection
- Data Request Form
- Attention Providers of Section 65, Behavioral Health Services, Crisis Resolution and Response: Draft Service Model and Provider Survey Tool Presented Materials
- Help with Food Costs as Extra COVID SNAP Funds End
- Hospital Price Transparency
DHHS → node